Dr. John K. Tsai, MD

Dr. Tsai practices at Austin GI Surgicenter, LLC in Austin, Texas.

Dr. Tsai's NPI, 1437321791, was assigned on March 27, 2008. Dr. Tsai graduated from Feinberg School of Medicine in 2001. Dr. Tsai holds Texas license R1466.

Dr. Tsai's primary practice is Austin GI Surgicenter, LLC, at 3944 S Farm To Market Road 620, Austin, TX 78738 in Travis County. The practice phone is (512) 532-8000.

Dr. Tsai's primary practice is Austin GI Surgicenter, LLC in Austin, Texas. Dr. Tsai is also affiliated with St. David's South Austin Medical Center. The medical group on file is Austin Gastroenterology. Dmand AI also links Dr. Tsai to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tsai practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Tsai's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Tsai is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Tsai's licenses on file in 3 states: Texas, Arizona and New York.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Tsai treats.

CMS data shows 1,022 Medicare services from Dr. Tsai across 11 procedure codes in 2024, for 588 Medicare patients. Medicare paid $104,441 for them.

CMS counts 588 Medicare patients who saw Dr. Tsai in 2024. The largest group is 65 to 74, with 360 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tsai's median patient age at 57, with 45% women.

In 2024, Dr. Tsai wrote 1,647 Medicare Part D claims for 554 patients. 83% of them were for generic drugs. CMS names the drug for 1,470 of them, across 21 drugs with 11 or more claims each, at $411,350 in total drug cost. In 2023, CMS named 1,198 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Tsai for performance year 2024, reported as part of a group. Dr. Tsai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tsai as offering telehealth. CMS counts 263 procedures of colonoscopy by Dr. Tsai, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Tsai. Dr. Tsai's most frequent co-author is Mark A. Schattner, MD.

CMS Open Payments shows 1,052 general payments to Dr. Tsai from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $5,477.

Dmand AI lists 2 awards for Dr. Tsai, most recently CMS Stage 1 EHR in 2013.

Dr. Tsai graduated from Feinberg School of Medicine in 2001. Dr. Tsai is a member of AGA and TMA.

Dr. Tsai is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.